Subscribe

Archive | Press Releases

AGP has added the beta-adrenoceptors blocker Glaten®

AGP - African Global Pharma Corp

Nov 12, 2012 African Global Pharma Corp.(AGP) has added the beta-adrenoceptors blocker Glaten® to its over-the-counter line of pharmaceuticals. It is being produced in African Global Pharma’s Ghana manufacturing facility. The medication contains Atenolol and is used for the treatment of hypertension, angina and myocardial infarction. Glaten® is being made available in 50mg tablets and joins […]

AGP has initiated the production of the anti-malarial pharmaceutical called Gloderp®

AGP - It's Great

Nov 1 2012 African Global Pharma Corp.(AGP) has initiated the production of the anti-malarial pharmaceutical called Gloderp®. It will be produced in capsule form in the (AGP) Ghana pharmaceutical manufacturing facility.   Gloderp® is used for the treatment of uncomplicated malaria caused by falciparum, vivax and or malariae. Each capsule will contain Dihydroartemisinin 40mg and […]

AGP has commenced production of the anti-malarial pharmaceutical Globartem®.

Oct 30, 2012 African Global Pharma Corp.(AGP) has commenced production of the anti-malarial pharmaceutical Globartem®. Globartem® is indicated for the treatment of uncomplicated malaria caused by multiple drug resistant strains of p. falciparum. AGP will produce the medicine in tablet form including a dispersible tablet for pediatric use. Each tablet contains Artemether 20mg and Lumefantrine […]